Contaminated Heparin distributed earlier than originally thought
New information is emerging in the ongoing saga of Heparin contamination. Baxter, the largest distributor of contaminated Heparin, represented on several occasions that the earliest date of distribution of its contaminated products is September of 2007. Scientific Protein Laboratories (SPL), the manufacture of Heparin API that was contaminated with Over Sulfated Chondroitin Sulfate (OSCS), for the most part has not issued a statement concerning when Heparin which contained OSCS was introduced into the market. Baxter had about 50% of the market, and AAP had most of the rest of the market.
New information has emerged that manufacturers other than Baxter received contaminated crude Heparin from SPL as far back as 2006, much earlier than when Baxter reports it received Heparin containing OSCS. Specifically B. Braun Medical and Tyco Healthcare (now Covidien) received contaminated Heparin from SPL as early as 2006.
Both companies have issued recalls of the contaminated product. Details of both recalls, including the products affected can be found in the Heparin Contamination article published on our Medical Injury Lawyer website.
